Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy.

OBJECTIVES To evaluate factors predicting cancer detection by extended repeat prostate biopsies in patients with an initial, isolated, monofocal or plurifocal, high-grade prostatic intraepithelial neoplasia (HGPIN) diagnosis. METHODS From 1995 to 2002, after a first set of 10 to 12 systematic biopsy cores, 47 patients with an initial HGPIN diagnosis underwent repeat biopsy using the same technique (mean repeat biopsy cores 11.5) after a median follow-up of 11.4 months (range 3 to 24). RESULTS Cancer was detected at the second biopsy in 21 patients (44.6%). Cancer detection was significantly greater in patients with plurifocal HGPIN than in those with monofocal HGPIN (70% vs. 10%, respectively; P <0.005) and in patients who underwent repeat biopsy more than 6 months after the first biopsy set (65%) compared with patients who underwent repeat biopsy within 6 months (25%; P <0.01; mean follow-up 15.5 and 3.8 months, respectively). Multivariate analysis showed that prostate-specific antigen, prostate-specific antigen density, digital rectal examination, and transrectal ultrasound findings were not statistically significant predictors of prostate cancer, and HGPIN multifocality and interval between biopsies (more than a 6-month follow-up interval) were independent prognostic factors (odds ratio 4.65 and 2.65, respectively). After radical prostatectomy (14 patients), no statistically significant differences were found in the pathologic stage between patient groups stratified by repeat biopsy interval (within or after 6 months). CONCLUSIONS After a 10 to 12-core biopsy, patients with initial, isolated monofocal or plurifocal HGPIN diagnoses had an overall cancer detection rate of 45% on repeat extended biopsies. Plurifocal HGPIN on the first biopsy set was the strongest independent predictive factor in cancer detection. A 12 to 18-month interval before repeat biopsy could permit a significantly greater cancer detection rate, with no apparent likelihood of clinical cancer progression.

[1]  F. Mostofi,et al.  Large acinar atypical hyperplasia and carcinoma of the prostate , 1988, Cancer.

[2]  J. Epstein,et al.  Follow-up of atypical prostate needle biopsies suspicious for cancer. , 1999, Urology.

[3]  G. Haas,et al.  The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. , 1993, The Journal of urology.

[4]  R. Bahnson,et al.  Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma. , 1986, The Journal of urology.

[5]  D. Bostwick,et al.  Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.

[6]  J. Melamed,et al.  Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. , 2002, The Journal of urology.

[7]  R. Hautmann,et al.  Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens. , 2001, Urology.

[8]  J. Roberts,et al.  Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. , 2001, The Journal of urology.

[9]  J. McNeal.  Morphogenesis of prostatic carcinoma , 1965, Cancer.

[10]  D. Bostwick.  Prostatic intraepithelial neoplasia (PIN): Current concepts , 1992, Journal of cellular biochemistry. Supplement.

[11]  P. Troncoso,et al.  Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. , 2000, The Journal of urology.

[12]  D. Grignon,et al.  Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. , 1989, Urology.

[13]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. , 1995, The Journal of urology.

[14]  P. Carroll,et al.  Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. , 2001, The Journal of urology.

[15]  S. Taneja,et al.  Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? , 2001, Urology.

[16]  P. Humphrey,et al.  Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. , 1996, The Journal of urology.

[17]  A. Sagalowsky,et al.  Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. , 1997, Urology.

[18]  D. Bostwick,et al.  The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. , 1995, The Journal of urology.

[19]  A. Zlotta,et al.  Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. , 1996, European Urology.

[20]  Mesut Remzi,et al.  Repeat prostate biopsy: who, how and when?. a review. , 2002, European urology.

[21]  H. Nisenbaum,et al.  Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. , 1996, The Journal of urology.

[22]  G. Raviv,et al.  Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? , 1996, Cancer.

[23]  S. Bigler,et al.  Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. , 2000, The Journal of urology.

[24]  C. Rosser,et al.  Detection of high-grade prostatic intraepithelial neoplasia with the five-region biopsy technique. , 1999, Urology.

[25]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia (PIN). , 1989, Urology.

[26]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.